Koshinski Asset Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $531K | Sell |
2,142
-35
| -2% | -$7.54K | 0.03% | 444 |
|
|
2026
Q1 | $437K | Sell |
2,177
-62
| -3% | -$12.8K | 0.03% | 472 |
|
|
2025
Q4 | $462K | Sell |
2,239
-359
| -14% | -$71.7K | 0.03% | 447 |
|
|
2025
Q3 | $466K | Sell |
2,598
-488
| -16% | -$83.1K | 0.03% | 445 |
|
|
2025
Q2 | $498K | Sell |
3,086
-73
| -2% | -$11.6K | 0.04% | 406 |
|
|
2025
Q1 | $537K | Sell |
3,159
-53
| -2% | -$9.21K | 0.05% | 360 |
|
|
2024
Q4 | $534K | Sell |
3,212
-139
| -4% | -$23.8K | 0.05% | 353 |
|
|
2024
Q3 | $576K | Buy |
+3,351
| New | +$555K | 0.05% | 337 |
|
|
2023
Q2 | – | Sell |
-5,193
| Closed | -$805K | – | 625 |
|
|
2023
Q1 | $805K | Buy |
5,193
+160
| +3% | +$25.1K | 0.08% | 246 |
|
|
2022
Q4 | $776K | Buy |
+5,033
| New | +$743K | 0.08% | 272 |
|
|
2022
Q3 | – | Sell |
-5,068
| Closed | -$687K | – | 590 |
|
|
2022
Q2 | $687K | Sell |
5,068
-16
| -0.3% | -$2.21K | 0.07% | 295 |
|
|
2022
Q1 | $758K | Buy |
5,084
+240
| +5% | +$35.5K | 0.06% | 305 |
|
|
2021
Q4 | $785K | Sell |
4,844
-144
| -3% | -$23.3K | 0.06% | 304 |
|
|
2021
Q3 | $828K | Buy |
4,988
+1,945
| +64% | +$332K | 0.07% | 293 |
|
|
2021
Q2 | $525K | Sell |
3,043
-2,047
| -40% | -$338K | 0.07% | 318 |
|
|
2021
Q1 | $817K | Buy |
+5,090
| New | +$871K | 0.09% | 262 |
|
|
2020
Q3 | – | Sell |
-5,208
| Closed | -$874K | – | 522 |
|
|
2020
Q2 | $874K | Buy |
5,208
+173
| +3% | +$27.2K | 0.14% | 184 |
|
|
2020
Q1 | $660K | Buy |
5,035
+1,016
| +25% | +$145K | 0.14% | 197 |
|
|
2019
Q4 | $596K | Buy |
4,019
+971
| +32% | +$133K | 0.1% | 275 |
|
|
2019
Q3 | $377K | Sell |
3,048
-35
| -1% | -$4.66K | 0.26% | 103 |
|
|
2019
Q2 | $434K | Sell |
3,083
-77
| -2% | -$10.6K | 0.18% | 157 |
|
|
2019
Q1 | $477K | Buy |
3,160
+944
| +43% | +$136K | 0.13% | 205 |
|
|
2018
Q4 | $275K | Buy |
+2,216
| New | +$303K | 0.07% | 320 |
|
|
2018
Q2 | – | Sell |
-2,224
| Closed | -$296K | – | 372 |
|
|
2018
Q1 | $296K | Buy |
2,224
+295
| +15% | +$40.3K | 0.09% | 287 |
|
|
2017
Q4 | $240K | Sell |
1,929
-530
| -22% | -$65.5K | 0.06% | 378 |
|
|
2017
Q3 | $305K | Buy |
2,459
+450
| +22% | +$53.3K | 0.1% | 288 |
|
|
2017
Q2 | $229K | Buy |
+2,009
| New | +$216K | 0.08% | 325 |
|
|
2015
Q4 | – | Sell |
-4,202
| Closed | -$521K | – | 228 |
|
|
2015
Q3 | $521K | Buy |
4,202
+1,103
| +36% | +$131K | 0.33% | 94 |
|
|
2015
Q2 | $384K | Buy |
3,099
+510
| +20% | +$61.6K | 0.24% | 125 |
|
|
2015
Q1 | $306K | Buy |
+2,589
| New | +$293K | 0.2% | 155 |
|
Other funds holding FBT
BFG
Koshinski Asset Management's FBT Position: Q2 2026 in Review
Koshinski Asset Management reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 1.6% in Q2 2026, selling an estimated $7.54K and leaving 2,142 shares worth $531K. The position accounts for 0.03% of the portfolio, ranked #444.
Koshinski Asset Management first reported a position in FBT in Q1 2015 and has held it in 30 quarters since. The position peaked at $874K in Q2 2020. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.
- Koshinski Asset Management held 2,142 shares of First Trust NYSE Arca Biotechnology Index Fund worth $531K as of Q2 2026.
- Koshinski Asset Management sold 35 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $7.54K.
- First Trust NYSE Arca Biotechnology Index Fund made up 0.03% of Koshinski Asset Management's portfolio in Q2 2026, its #444 holding.
- Koshinski Asset Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2015 and has held it in 30 quarters since.
- Koshinski Asset Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $874K in Q2 2020.
- 339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.
Based on Koshinski Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.